We are live on ! Find out more
ALDX icon

Aldeyra Therapeutics
ALDX

45 hedge funds and large institutions have $77.1M invested in Aldeyra Therapeutics in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

280% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 5

175% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 4

18% more funds holding

Funds holding: 38 → 45 (+7)

16% more capital invested

Capital invested by funds: $66.5M → $77.1M (+$10.6M)

2.65% more ownership

Funds ownership: 51.14% → 53.79% (+2.7%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
45
Holders Change
+7
Holders Change %
+18.42%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
19
Reduced
5
Closed
4
Calls
$377K
Puts
–
Net Calls
+$377K
Net Calls Change
+$377K

Top Buyers

1
MP
Mangrove Partners
Connecticut
+$1.21M
2
6CM
683 Capital Management
New York
+$645K
3
SLG
Stanley-Laman Group
Pennsylvania
+$486K
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$433K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$335K

Top Sellers

1
SFM
Sphera Funds Management
Israel
-$266K
2
Renaissance Technologies
Renaissance Technologies
New York
-$239K
3
OAM
Oxford Asset Management
United Kingdom
-$95K
4
WMSA
Weiss Multi-Strategy Advisers
New York
-$19.7K
5
AIS
AlphaOne Investment Services
Pennsylvania
-$16K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$23.1M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$12.1M – – –
SFM
3
Sphera Funds Management
Israel
$7.57M -$266K -35,000 -3%
6CM
4
683 Capital Management
New York
$7.5M +$645K +85,000 +9%
Millennium Management
5
Millennium Management
New York
$5.65M +$284K +37,464 +5%
Adage Capital Partners
6
Adage Capital Partners
Massachusetts
$5.63M +$433K +57,000 +8%
Vanguard Group
7
Vanguard Group
Pennsylvania
$5.23M -$6.83K -900 -0.1%
MP
8
Mangrove Partners
Connecticut
$2.43M +$1.21M +159,635 +97%
KCM
9
Knoll Capital Management
Florida
$931K – – –
HP
10
Hikari Power
Japan
$809K – – –
Geode Capital Management
11
Geode Capital Management
Massachusetts
$766K – – –
WC
12
Woodstock Corp
Massachusetts
$508K +$72.2K +9,516 +16%
SLG
13
Stanley-Laman Group
Pennsylvania
$480K +$486K +64,029 New
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
$468K +$87.3K +11,506 +23%
JP Morgan Chase
15
JP Morgan Chase
New York
$446K +$74.6K +9,826 +20%
Northern Trust
16
Northern Trust
Illinois
$361K +$93.3K +12,290 +34%
WMSA
17
Weiss Multi-Strategy Advisers
New York
$356K -$19.7K -2,600 -5%
AAP
18
Ardsley Advisory Partners
Connecticut
$336K – – –
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$331K +$335K +44,084 New
BlackRock
20
BlackRock
New York
$296K +$13K +1,713 +5%
Renaissance Technologies
21
Renaissance Technologies
New York
$230K -$239K -31,500 -51%
State Street
22
State Street
Massachusetts
$194K +$24.8K +3,262 +14%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$156K +$18.3K +2,413 +13%
HighTower Advisors
24
HighTower Advisors
Illinois
$145K +$22.8K +3,000 +18%
ECM
25
Element Capital Management
New York
$123K +$125K +16,431 New
1
2

ALDX Hedge Fund Activity: Q1 2018 in Review

45 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q1 2018, worth a combined $77.1M — up 16% from $66.5M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new ALDX positions and 4 closed out — a net gain of 7 holders — while 19 added to existing stakes and 5 trimmed.

The largest buyer was Mangrove Partners, adding an estimated $1.21M. The largest seller was Sphera Funds Management, cutting an estimated $266K.

  • 45 institutional investors held Aldeyra Therapeutics (ALDX) as of Q1 2018, up from 38 in Q4 2017.
  • Funds reported $77.1M of Aldeyra Therapeutics stock for Q1 2018, up 16% quarter-over-quarter.
  • 11 funds opened new Aldeyra Therapeutics positions in Q1 2018 and 4 closed out, a net change of +7 holders.
  • The largest Aldeyra Therapeutics buyer in Q1 2018 was Mangrove Partners, an estimated $1.21M added.
  • The largest Aldeyra Therapeutics seller in Q1 2018 was Sphera Funds Management, an estimated $266K sold.

Based on aggregated 13F filings for Q1 2018.